Patients Benefit from GHLF’s Launch of Interactive Guide for Hidradenitis Suppurativa The Global Healthy Living Foundation (GHLF) has unveiled a new resource aimed at supporting those living with Hidradenitis Suppurativa (HS). The “Interactive Patient Guide to Hidradenitis Suppurativa” is designed…
Cancer Trial Data for FOG-001 to be Presented by Parabilis at ASCO GI Cancers Symposium Parabilis Medicines, formerly known as Fog Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing transformative treatments for cancer patients, today announced that it will present…
Clinical Data Registry: McKesson’s Practice Insights Named 2025 QCDR by CMS For the ninth year in a row, McKesson has been named a Qualified Clinical Data Registry (QCDR) by the Centers for Medicare & Medicaid Services (CMS), securing approval to…
Verastem Oncology Unveils Bold 2025 Priorities for RAS/MAPK Pathway Cancer Pipeline Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing new treatments for RAS/MAPK pathway-driven cancers, has outlined its strategic priorities for 2025, as well as the key milestones…
Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive Ultherapy® skin lifting technology. This advanced version of Ultherapy® promises…
Viruses Neutralized by Electromagnetic Waves: e4life at Arab Health Dubai e4life will play a key role at the landmark 50th edition of Arab Health, the premier health trade fair in the Middle East. The Italian company will showcase its cutting-edge…
Innovation by USound Enables Advanced Health Monitoring in TWS Earphones USound, a global leader in Micro Electronic Mechanical Systems (MEMS) speakers, has unveiled a groundbreaking innovation that will enable true wireless systems (TWS) earphones to feature advanced health monitoring capabilities…
Diabetes Breakthrough: IPA Pioneers AI-Designed GLP-1 Therapies ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has pioneered a new class of GLP-1 therapies developed entirely through artificial intelligence, aiming to enhance the efficacy, safety, longevity, and patient satisfaction in diabetes treatment. These…
Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA Vaxxas, a clinical-stage biotechnology company focused on commercializing its innovative high-density microarray patch (HD-MAP) vaccination platform, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) has approved the…
Collaboration Announced Between Simulations Plus and ETC for GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), a leader in biosimulation and performance solutions for the biopharma industry, has entered into an exciting new collaboration with the Enabling Technologies Consortium (ETC). This funded…
